OncoSec Medical Names Adil Daud, M.D. as Chief Clinical Strategist

OncoSec Medical Inc. , a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, has named Adil Daud, M.D. as Chief Clinical Strategist.



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1ieQsqi

via IFTTT